Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells
- 11 August 2004
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 41 (3) , 203-213
Abstract
The human L3MBTL gene is located in 20q12, a region that is commonly deleted in myeloproliferative disorders (MPD), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). L3MBTL is highly homologous to the D‐lethal(3) malignant brain tumor [D‐l(3)mbt] gene, which is a putative tumor‐suppressor gene (TSG) identified in Drosophila and which is closely related to the Drosophila sex combs on midleg (SCM) protein, a member of the Polycomb group (PcG) family of transcriptional repressors. To examine whether L3MBTL functions as a “classic” TSG in human hematologic malignancies, we screened a panel of 17 myeloid leukemia cell lines and peripheral blood or bone marrow samples from 29 MDS and 13 MPD patients for mutations in the entire L3MBTL coding sequence, including intron/exon splice junctions. No mutations were identified, although two single nucleotide differences were found (in intron 14 and in exon 15), which were interpreted as polymorphic changes. We used real‐time RT‐PCR to quantify the level of L3MBTL mRNA in various normal myeloid and lymphoid cell populations. L3MBTL is expressed in normal CD34+ bone marrow cells, and we found that the pattern of L3MBTL expression was similar to that of BMI1, a well‐studied PcG gene with oncogenic activity, suggesting that L3MBTL and BMI1 may be co‐regulated during hematopoiesis. The expression of L3MBTL mRNA in 30 of 35 cell lines and 13 of 15 AML samples was comparable to the level of L3MBTL expression in the normal cell populations. However, five leukemia cell lines showed no L3MBTL expression, and two of the AML samples showed aberrant L3MBTL expression. These data suggest that L3MBTL is not mutated in MDS or MPD. However, given the known dosage effects of PcG proteins in regulating gene expression, reduced or absent L3MBTL expression may be relevant in some cases of myeloid leukemia.Keywords
This publication has 43 references indexed in Scilit:
- Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomasNature, 2004
- Malignant Brain Tumor Repeats: A Three-Leaved Propeller Architecture with Ligand/Peptide Binding PocketsStructure, 2003
- Ezh2 controls B cell development through histone H3 methylation and Igh rearrangementNature Immunology, 2002
- Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell linesOncogene, 2001
- Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stageExperimental Hematology, 2001
- Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genesOncogene, 2000
- Refinement of the Smallest Commonly Deleted Segment of Chromosome 20 in Malignant Myeloid Diseases and Development of a PAC-Based Physical and Transcription MapGenomics, 2000
- A human homolog of Drosophila lethal(3)malignant brain tumor (l(3)mbt) protein associates with condensed mitotic chromosomesOncogene, 1999
- The Drosophila melanogaster tumor suppressor gene lethal(3)malignant brain tumor encodes a proline-rich protein with a novel zinc fingerMechanisms of Development, 1995
- A temperature-sensitive brain tumor suppressor mutation of Drosophila melanogaster: Developmental studies and molecular localization of the geneMechanisms of Development, 1993